Status
Conditions
Treatments
About
The prevalence of hypothermia across low-resource settings is high, especially in countries with high neonatal mortality rates. If left untreated, hypothermia can additionally result in a significant comorbidity, and has been linked to a reduction in the effectiveness of treatment for other newborn conditions. Thermal care for hypothermic newborns is not widely available in low-resource settings due to cost, and lack of consumables and spare parts. In this study, the research team will evaluate the efficacy of a novel neonatal warming mattress intreating hypothermic newborns. The warming mattress, 'Celsi Warmer', has been developed by Rice360 Institute for Global Health Technologies, in conjunction with African clinicians, to be a robust, low-cost, and easy-to-use warming mattress which can address the challenges of hypothermia. This is a single-arm, non-randomized, prospective intervention study. Up to90eligible infants at Muhimbili National Hospital (MNH) at Upanga Neonatal Unit will be recruited to evaluate the efficacy of Celsi Warmer in rewarming hypothermic newborns. Infants temperature will be monitored during thermal intervention and the performance of the device will be evaluated. The temperatures of each infant will be compared before, during, and after the intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Any neonate who:
The study will not interfere with any other treatment being provided at the ward, and it will not delay the participant from transferring to KMC or being discharged
Exclusion criteria
Any neonate who:
Primary purpose
Allocation
Interventional model
Masking
90 participants in 1 patient group
Loading...
Central trial contact
Rebecca Massey, MPH, BSN, RN; Sonia Sosa Saenz, BME
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal